Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.65
Bid: 18.50
Ask: 18.80
Change: -0.10 (-0.53%)
Spread: 0.30 (1.622%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on refinancing and current trading

17 Aug 2020 07:00

RNS Number : 2539W
Carclo plc
17 August 2020
 

Carclo plc

 

("Carclo" or "the Group" or "the Company")

 

Update on refinancing and current trading

 

 

Tripartite financing agreement secured

 

The Board announces that on 14 August 2020, the Group agreed revised funding arrangements with the Company's main secured creditors, HSBC and the Pension Scheme, which provide access to ongoing bank facilities as well as visibility over repayment schedules through to July 2023.

 

As part of this agreement, new facilities have been entered into with the Group's lending bank, HSBC, which comprise a Term Loan of £34.5m and a Revolving Credit Facility of £3.5m. In parallel to this, the Group reached agreement with the Trustees of the Pension Scheme in respect of both the actuarial deficit and the resultant deficit repair contributions to be made over the next three years; £2.8m (2021), £3.9m (2022) and £3.8m (2023).

 

As previously announced, securing a suitable long-term funding position for the Group has been a key focus of the Board. With a more stable base now established, the Board can turn its focus to delivering its growth strategy aimed at capturing the significant long-term opportunities it sees for the Group.

 

Update on current trading

 

Group revenue for the continuing businesses for the first quarter was 12% lower than the same period last year. In anticipation of a material reduction in activity in both businesses during the first quarter, the Group implemented a number of operating and commercial initiatives aimed at preserving operational continuity as well as matching cost to reduced demand. The Group has also been able to access Covid-19 relief schemes, particularly in relation to job retention programmes, in a number of its territories including for the UK and US operations. As a result of an effective response by the business, and more resilient demand conditions in certain segments, the overall trading performance in the first quarter of the Group's current financial year to 31 March 2021 was ahead of the Board's initial, Covid-19 adjusted, planning assumptions with both the Technical Plastics and Aerospace divisions recording encouraging performances. Group net debt excluding IFRS16 lease liabilities as at 27 June 2020 was £24.2m (31 March 2020: £22.1m).

 

The Technical Plastics business benefited from robust demand for products relating to Covid-19 testing, which partially offset a reduction in demand for other products in both the medical diagnostics and industrial sectors that had been exacerbated by the impact of government-imposed lockdown of a customer's facility in India. The business was also successful in securing a number of new tooling orders in the medical diagnostics sector which are expected to deliver significant production volumes in future years.

 

The Aerospace Division performed better than anticipated in the first quarter, largely as a result of continued offtake from the existing orderbook, which partly offset the impact of a significant reduction in both newbuild and spares demand from Airbus.

 

Outlook

 

In light of the ongoing uncertainty presented by the pandemic, as well as any wider resultant economic impacts, the Board does not believe that it is possible to provide detailed guidance for the year ending 31 March 2021 at this time. Activity levels in July were broadly in line with those seen in the first quarter and the Board remains cautious about market conditions in the near term. The Group will continue to take action to reduce its cost base, where appropriate, to mitigate the effect of any reduction in demand, whilst seeking to preserve the capability and capacity to respond positively as conditions improve.

 

The Board expects to release the Group's preliminary results on 25 August 2020.

 

Enquiries:

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKABKDBKBAFD
Date   Source Headline
20th Jul 20112:06 pmRNSPerformance Share Plan
8th Jul 20114:03 pmRNSIssue of Equity
8th Jul 20113:57 pmRNSBlocklisting Interim Review
7th Jul 20112:13 pmRNSHolding(s) in Company
7th Jul 20112:11 pmRNSHolding(s) in Company
29th Jun 20111:50 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSPre-close Trading Statement
28th Mar 20112:28 pmRNSHolding(s) in Company
9th Feb 20117:00 amRNSInterim Management Statement
28th Jan 201111:46 amRNSHolding(s) in Company
18th Jan 201111:02 amRNSHolding(s) in Company
17th Jan 20114:06 pmRNSHolding(s) in Company
13th Jan 20114:14 pmRNSHolding(s) in Company
16th Dec 20104:40 pmRNSSecond Price Monitoring Extn
16th Dec 20104:35 pmRNSPrice Monitoring Extension
7th Dec 20103:06 pmRNSDirector/PDMR Shareholding
23rd Nov 20107:00 amRNSHalf Yearly Report
10th Nov 20101:45 pmRNSHolding(s) in Company
8th Nov 20102:12 pmRNSHolding(s) in Company
3rd Nov 20101:58 pmRNSHolding(s) in Company
29th Oct 20104:40 pmRNSSecond Price Monitoring Extn
29th Oct 20104:35 pmRNSPrice Monitoring Extension
29th Oct 201012:07 pmRNSHolding(s) in Company
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:35 pmRNSPrice Monitoring Extension
21st Oct 20104:35 pmRNSPrice Monitoring Extension
4th Oct 20107:00 amRNSTrading Update
30th Sep 20109:40 amRNSTotal Voting Rights
8th Sep 20107:30 amRNSPerformance Share Plan
3rd Sep 20107:00 amRNSResult of AGM
26th Aug 20104:40 pmRNSSecond Price Monitoring Extn
26th Aug 20104:35 pmRNSPrice Monitoring Extension
18th Aug 20103:26 pmRNSBlock listing application
16th Aug 20107:00 amRNSInterim Management Statement
30th Jul 20108:15 amRNSTotal Voting Rights
30th Jul 20108:00 amRNSIssue of Equity
12th Jul 201011:55 amRNSPerformance Share Plan
12th Jul 201011:45 amRNSHolding(s) in Company
12th Jul 201011:35 amRNSHolding(s) in Company
5th Jul 201011:29 amRNSDirector/PDMR Shareholding
2nd Jul 20103:17 pmRNSTotal Voting Rights
2nd Jul 20103:12 pmRNSHolding(s) in Company
1st Jul 20109:19 amRNSIssue of Equity
25th Jun 201011:45 amRNSHolding(s) in Company
23rd Jun 20103:11 pmRNSHolding(s) in Company
15th Jun 201011:07 amRNSDirector/PDMR Shareholding
10th Jun 20109:25 amRNSDirector/PDMR Shareholding
8th Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.